Cardiopulmonary exercise testing reveals subclinical abnormalities in chronic kidney disease

Abstract

Background

Reductions in exercise capacity associated with exercise intolerance augment cardiovascular disease risk and predict mortality in chronic kidney disease. This study utilized cardiopulmonary exercise testing to (a) investigate mechanisms of exercise intolerance; (b) unmask subclinical abnormalities that may precede cardiovascular disease in chronic kidney disease.

Design

The design of this study was cross-sectional.

Methods

Cardiopulmonary exercise testing was carried out in 31 Stage 3–4 chronic kidney disease patients (60 ± 11 years; estimated glomerular filtration rate 43 ± 13 ml/min/1.73 m²) and 21 matched healthy individuals (healthy controls; 56 ± 5 years; estimated glomerular filtration rate>90 ml/min/1.73 m²) on a cycle ergometer with workload increased by 15 W every minute until volitional fatigue. Breath-by-breath respiratory gas analysis was performed with an automated gas analyzer and averaged over 10 s intervals.

Results

Peak oxygen uptake was reduced in chronic kidney disease compared to healthy controls (17.43 ± 1.03 vs 28 ± 2.05 ml/kg/min; p < 0.01), as was oxygen uptake at the ventilatory threshold (9.44 ± 0.53 vs15.55 ± 1.34 ml/kg/min; p < 0.01). A steeper minute ventilation rate/carbon dioxide production slope (32 ± 0.8 vs 28 ± 1; p < 0.01) and a lower expired carbon dioxide pressure in chronic kidney disease (27 ± 0.6 vs 31 ± 0.9 vs 0.9; p < 0.01) indicated ventilation perfusion mismatching in these patients. The ventilatory cost of oxygen uptake was higher in chronic kidney disease (37 ± 0.8 vs 33 ± 1; p < 0.01). Maximum heart rate (134 ± 5 vs 159 ± 3 bpm) and one-minute heart rate recovery (15 ± 1 vs 20 ± 2 bpm) were reduced in chronic kidney disease (p < 0.01).

Conclusion

This study suggests that both central and peripheral limitations likely contribute to reduced exercise capacity in non-dialysis chronic kidney disease. Additionally, cardiopulmonary exercise testing revealed subclinical cardiopulmonary abnormalities in these patients in the absence of overt cardiovascular disease. Cardiopulmonary exercise testing could potentially be a tool for unmasking cardiopulmonary abnormalities preceding cardiovascular disease in chronic kidney disease.

Keywords

Chronic renal insufficiency exercise test

Get full access to this article

View all access options for this article.

References

Saran

Robinson

Abbott

et al.

US Renal Data System 2016 annual data report: Epidemiology of kidney disease in the United States. Am J Kidney Dis 2017; 67: A7–A8.

Macdonald

Fearn

Jibani

et al.

Exertional fatigue in patients with CKD. Am J Kidney Dis 2012; 60: 930–939.

Howden

Weston

Leano

et al.

Cardiorespiratory fitness and cardiovascular burden in chronic kidney disease. J Sci Med Sport 2015; 18: 492–497.

Lopes

Lantz

Morgenstern

et al.

Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: The DOPPS. Clin J Am Soc Nephrol 2014; 9: 1702–1712.

Sietsema

Amato

Adler

et al.

Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int 2004; 65: 719–724.

Sakkas

Ball

Mercer

et al.

Atrophy of non-locomotor muscle in patients with end-stage renal failure. Nephrol Dialysis Transplant 2003; 18: 2074–2081.

Stray-Gundersen

Howden

Parsons

et al.

Neither hematocrit normalization nor exercise training restores oxygen consumption to normal levels in hemodialysis patients. J Am Soc Nephrol 2016; 27: 3769–3779.

Gibbons

Balady

Bricker

. ACC/AHA 2002 guideline update for exercise testing: Summary article: A report of the American College of Cardiology American Heart Association task force on practice guidelines. J Am Coll Cardiol 2006; 48: 1731–1731.

Shafiq

Brawner

Aldred

et al.

Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project. Am Heart J 2016; 174: 167–172.

10.

Levey

Coresh

Balk

et al.

National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137–147.

11.

Pescatello

. ACSM's guidelines for exercise testing and prescription, 9th ed. Baltimore, MD: Lipincott Williams and Wilkins, 2014.

12.

Baba

Nagashima

Goto

et al.

Oxygen uptake efficiency slope: A new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 1996; 28: 1567–1572.

13.

Koufaki

Naish

Mercer

. Reproducibility of exercise tolerance in patients with end-stage renal disease. Arch Phys Med Rehabil 2001; 82: 1421–1424.

14.

Guazzi

Arena

Halle

et al.

2016 focused update: Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 2016; 133: e694–e711.

15.

Ifudu

Paul

Mayers

et al.

Pervasive failed rehabilitation in center-based maintenance hemodialysis-patients. Am J Kidney Dis 1994; 23: 394–400.

16.

Greenwood

Koufaki

Mercer

et al.

Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: A pilot randomized controlled trial. Am J Kidney Dis 2015; 65: 425–434.

17.

Headley

Germain

Milch

et al.

Exercise training improves HR responses and VO_2peak in predialysis kidney patients. Med Sci Sports Exerc 2012; 44: 2392–2399.

18.

Nelson

Otto

Whittle

et al.

Subclinical cardiopulmonary dysfunction in stage 3 chronic kidney disease. Open Heart 2016; 3: e000370–e000370.

19.

Sato

Yoshihisa

Kanno

et al.

Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction. Eur J Prev Cardiol 2017; 24: 1979–1987.

20.

Poggio

Arazi

Giorgi

et al.

Prediction of severe cardiovascular events by VE/VCO2 slope versus peak VO2 in systolic heart failure: A meta-analysis of the published literature. Am Heart J 2010; 160: 1004–1014.

21.

Finocchiaro

Haddad

Knowles

et al.

Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy a potential role for comprehensive noninvasive hemodynamic assessment. JACC Heart Fail 2015; 3: 408–418.

22.

Ferreira

EVM

Ota-Arakaki

Ramos

et al.

Optimizing the evaluation of excess exercise ventilation for prognosis assessment in pulmonary arterial hypertension. Eur J Prev Cardiol 2014; 21: 1409–1419.

23.

Ferrazza

Martolini

Valli

et al.

Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration 2009; 77: 3–17.

24.

Guazzi

Borlaug

. Pulmonary hypertension due to left heart disease. Circulation 2012; 126: 975–990.

25.

Navaneethan

Roy

Tao

et al.

Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J Am Soc Nephrol 2016; 27: 877–886.

26.

Martens

Kirkman

Edwards

. The vascular endothelium in chronic kidney disease: A novel target for aerobic exercise. Exerc Sport Sci Rev 2016; 27: 877–886.

27.

Cooper

Landzberg

Anderson

et al.

Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans. Circulation 1996; 93: 266–271.

28.

Bush

Gabriel

. Pulmonary-function in chronic-renal-failure – effects of dialysis and transplantation. Thorax 1991; 46: 424–428.

29.

Guazzi

. The ultimate diagnosis of unexplained dyspnoea on exertion: Stay tuned on invasive cardiopulmonary exercise testing and beyond. Eur J Prev Cardiol 2017; 24: 1308–1310.

30.

Taivassalo

Jensen

Kennaway

et al.

The spectrum of exercise tolerance in mitochondrial myopathies: A study of 40 patients. Brain 2003; 126: 413–423.

31.

Yazdi

Moradi

Yang

et al.

Skeletal muscle mitochondrial depletion and dysfunction in chronic kidney disease. Int J Clin Exp Med 2013; 6: 532–539.

32.

Chrysohoou

Skoumas

Georgiopoulos

et al.

Exercise capacity and haemodynamic response among 12,327 individuals with cardio-metabolic risk factors undergoing treadmill exercise. Eur J Prev Cardiol 2017; 24: 1627–1636.

33.

Suminski

Robertson

Goss

et al.

Peak oxygen consumption and skeletal muscle bioenergetics in African-American and Caucasian men. Med Sci Sports Exerc 2000; 32: 2059–2066.